281 related articles for article (PubMed ID: 29218504)
41. Modeling Parkinson's disease falls associated with brainstem cholinergic systems decline.
Kucinski A; Sarter M
Behav Neurosci; 2015 Apr; 129(2):96-104. PubMed ID: 25798629
[TBL] [Abstract][Full Text] [Related]
42. Effect of neurotoxic lesion of pedunculopontine nucleus in nigral and striatal redox balance and motor performance in rats.
Jimenez-Martin J; Blanco-Lezcano L; González-Fraguela ME; Díaz-Hung ML; Serrano-Sánchez T; Almenares JL; Francis-Turner L
Neuroscience; 2015 Mar; 289():300-14. PubMed ID: 25596320
[TBL] [Abstract][Full Text] [Related]
43. The Cellular Diversity of the Pedunculopontine Nucleus: Relevance to Behavior in Health and Aspects of Parkinson's Disease.
Pienaar IS; Vernon A; Winn P
Neuroscientist; 2017 Aug; 23(4):415-431. PubMed ID: 27932591
[TBL] [Abstract][Full Text] [Related]
44. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
Müller ML; Albin RL; Kotagal V; Koeppe RA; Scott PJ; Frey KA; Bohnen NI
Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
[TBL] [Abstract][Full Text] [Related]
45. Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.
Vernon AC; Johansson SM; Modo MM
BMC Neurosci; 2010 Jan; 11():1. PubMed ID: 20051106
[TBL] [Abstract][Full Text] [Related]
46. Dopaminergic but not cholinergic neurodegeneration is correlated with gait disturbances in PINK1 knockout rats.
DeAngelo VM; Hilliard JD; McConnell GC
Behav Brain Res; 2022 Jan; 417():113575. PubMed ID: 34534596
[TBL] [Abstract][Full Text] [Related]
47. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat.
Breit S; Bouali-Benazzouz R; Benabid AL; Benazzouz A
Eur J Neurosci; 2001 Dec; 14(11):1833-42. PubMed ID: 11860479
[TBL] [Abstract][Full Text] [Related]
48. Glutamatergic and cholinergic pedunculopontine neurons innervate the thalamic parafascicular nucleus in rats: changes following experimental parkinsonism.
Barroso-Chinea P; Rico AJ; Conte-Perales L; Gómez-Bautista V; Luquin N; Sierra S; Roda E; Lanciego JL
Brain Struct Funct; 2011 Nov; 216(4):319-30. PubMed ID: 21499800
[TBL] [Abstract][Full Text] [Related]
49. Pedunculopontine nucleus in the squirrel monkey: distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons.
Lavoie B; Parent A
J Comp Neurol; 1994 Jun; 344(2):190-209. PubMed ID: 7915726
[TBL] [Abstract][Full Text] [Related]
50. Chronic L-DOPA treatment attenuates behavioral and biochemical deficits induced by unilateral lactacystin administration into the rat substantia nigra.
Konieczny J; Czarnecka A; Lenda T; Kamińska K; Lorenc-Koci E
Behav Brain Res; 2014 Mar; 261():79-88. PubMed ID: 24361083
[TBL] [Abstract][Full Text] [Related]
51. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Aponso PM; Faull RL; Connor B
Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
[TBL] [Abstract][Full Text] [Related]
52. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
Coune PG; Bensadoun JC; Aebischer P; Schneider BL
J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
[TBL] [Abstract][Full Text] [Related]
53. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
[TBL] [Abstract][Full Text] [Related]
54. Divergent motor projections from the pedunculopontine nucleus are differentially regulated in Parkinsonism.
Martinez-Gonzalez C; van Andel J; Bolam JP; Mena-Segovia J
Brain Struct Funct; 2014 Jul; 219(4):1451-62. PubMed ID: 23708060
[TBL] [Abstract][Full Text] [Related]
55. Whole-brain mapping of monosynaptic inputs to midbrain cholinergic neurons.
Huerta-Ocampo I; Dautan D; Gut NK; Khan B; Mena-Segovia J
Sci Rep; 2021 Apr; 11(1):9055. PubMed ID: 33907215
[TBL] [Abstract][Full Text] [Related]
56. [Effects of unilateral lesion of the nigrostriatal pathway by 6-OHDA on the neuronal activities of the pedunculopontine nucleus and the ventrolateral thalamic nucleus].
Liu H; Zhang J; Gao DM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):212-6. PubMed ID: 21189555
[TBL] [Abstract][Full Text] [Related]
57. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.
Höglinger GU; Féger J; Prigent A; Michel PP; Parain K; Champy P; Ruberg M; Oertel WH; Hirsch EC
J Neurochem; 2003 Feb; 84(3):491-502. PubMed ID: 12558969
[TBL] [Abstract][Full Text] [Related]
58. A cholinergic projection to the rat superior colliculus demonstrated by retrograde transport of horseradish peroxidase and choline acetyltransferase immunohistochemistry.
Beninato M; Spencer RF
J Comp Neurol; 1986 Nov; 253(4):525-38. PubMed ID: 3540040
[TBL] [Abstract][Full Text] [Related]
59. Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors.
Harrison IF; Crum WR; Vernon AC; Dexter DT
Br J Pharmacol; 2015 Aug; 172(16):4200-15. PubMed ID: 26040297
[TBL] [Abstract][Full Text] [Related]
60. Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients.
Rinne JO; Ma SY; Lee MS; Collan Y; Röyttä M
Parkinsonism Relat Disord; 2008 Nov; 14(7):553-7. PubMed ID: 18329941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
